Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - nerida+wilson
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Antimalarial peptides
Competitive Advantages Potential treatment for malaria Could be effective against drug resistant strain Dd2 The resulting compounds showed no significant cytotoxicity Summary Malaria, caused by the parasite Plasmodium falciparum, continues to threaten much of the world population and there is a pressing need for expanding treatment options....
Published: 11/7/2024
|
Inventor(s):
Bill Baker
,
Joe Bracegirdle
,
James Rocca
,
John Adams
,
Nerida Wilson
,
Debora Casandra
,
Xingmin Sun
,
Anne-Claire Limon
Keywords(s):
Infectious Diseases Treatment
,
Peptides
,
Therapeutics
Category(s):
Technology Classifications > Chemistry
,
Technology Classifications > Medical > Infectious Diseases
Leishmania Inhibitors Derived from Deep-Sea Coral
Competitive Advantages Specific inhibition of Leishmania donovani parasites A natural drug candidate Does not produce toxic side effects Summary Our researchers have identified a novel metabolite derived from an Antarctic marine coral that shows promise as a new treatment option for leishmaniasis infections. Antactic marine invertebrates are...
Published: 11/7/2024
|
Inventor(s):
Bill Baker
,
Nerida Wilson
,
Dennis Kyle
,
Anne-Claire Limon
Keywords(s):
Category(s):
Technology Classifications > Medical > Infectious Diseases
,
Technology Classifications > Medical
Friomaramide, a Novel Hexapeptide, Inhibits Liver Stage Plasmodium Falciparum
Competitive Advantages A novel molecule that can inhibit P. falciparum in malaria Bypasses drug resistance Limited toxicity towards human cells Summary USF researchers have developed a novel modified hexapeptide called friomaramide. It inhibits the growth of P. falciparum to a similar degree as the antimalarial drug primaquine, with the added...
Published: 11/7/2024
|
Inventor(s):
Bill Baker
,
Nerida Wilson
,
John Adams
,
Alison Roth
,
Matthew Knestrick
Keywords(s):
Category(s):
Technology Classifications > Medical > Pharmaceuticals
,
Technology Classifications > Medical > Infectious Diseases
,
Technology Classifications > Medical